Literature DB >> 30728670

Interrelation of the Circulating and Tissue MicroRNA-21 with Tissue PDCD4 Expression and the Invasiveness of Iraqi Female Breast Tumors.

Meena M Abdulhussain1, Najat A Hasan1, Alaa G Hussain2.   

Abstract

The changes in the translational repression and variation in mRNA degradation induced by micro RNA are important aspects of tumorigenesis. The association of microRNA-21 with clinicopathologic features and expression of programed cell death 4 (PDCD4) in Iraqi female's with breast tumors has not been studied. MicroRNAs were extracted from a set of 60 breast tumor tissues and blood samples of females with breast cancer and benign breast lesions obtained after breast-reductive surgery, and only blood samples from 30 normal volunteers. These extracts were evaluated for miR-21 expression by quantitative RT-PCR. Analysis of PDCD4 protein expression was carried out as miR-21 target gene by immunohistochemical tests and correlating the results with patients' clinicopathological features. Significant overexpression of miRNA-21 was found in breast cancer group. The fold increase in the miR-21 gene expression was significantly higher in circulating exosomes and breast tissues of breast cancer patients as compared to other groups (P < 0.001). Overexpression of miR-21 was also significantly associated with the advanced tumor stage and histological grade. In breast cancer patients, PDCD4 protein expression was decreased to about 70% of the level in the control group. The delta Ct of exosomal and breast tissue miRNA-21 was negatively associated with PDCD4 expression. In conclusion, the translational repression of the PDCD4 induced by the high expression of miR-21 promotes breast cell transformation and development of breast tumor, and circulating miR-21 level could be applied to the screening panels for early detection of women breast cancer.

Entities:  

Keywords:  Benign breast lesion; Breast cancer; MicroRNA-21; Programed death cell 4

Year:  2017        PMID: 30728670      PMCID: PMC6346619          DOI: 10.1007/s12291-017-0710-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  43 in total

1.  The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA.

Authors:  Maret Böhm; Kirsty Sawicka; Jan Peter Siebrasse; Anne Brehmer-Fastnacht; Reiner Peters; Karl-Heinz Klempnauer
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.

Authors:  J H Leupold; H-S Yang; N H Colburn; I Asangani; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

5.  miR-21-mediated tumor growth.

Authors:  M-L Si; S Zhu; H Wu; Z Lu; F Wu; Y-Y Mo
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

6.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

8.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

Authors:  I A Asangani; S A K Rasheed; D A Nikolova; J H Leupold; N H Colburn; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

9.  MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

Authors:  Shuomin Zhu; Min-Liang Si; Hailong Wu; Yin-Yuan Mo
Journal:  J Biol Chem       Date:  2007-03-15       Impact factor: 5.157

10.  The decrease in breast-cancer incidence in 2003 in the United States.

Authors:  Peter M Ravdin; Kathleen A Cronin; Nadia Howlader; Christine D Berg; Rowan T Chlebowski; Eric J Feuer; Brenda K Edwards; Donald A Berry
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

View more
  7 in total

Review 1.  Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.

Authors:  Vaishali Aggarwal; Kumari Priyanka; Hardeep Singh Tuli
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

Review 2.  The Emerging Role of MicroRNAs in Breast Cancer.

Authors:  Zhiguang Yang; Zhaoyu Liu
Journal:  J Oncol       Date:  2020-07-03       Impact factor: 4.375

Review 3.  Circulating Extracellular Vesicle MicroRNA as Diagnostic Biomarkers in Early Colorectal Cancer-A Review.

Authors:  Brendan J Desmond; Elizabeth R Dennett; Kirsty M Danielson
Journal:  Cancers (Basel)       Date:  2019-12-23       Impact factor: 6.639

Review 4.  Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.

Authors:  Hsing-Ju Wu; Pei-Yi Chu
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

Review 5.  The role of Exosomal miRNAs in cancer.

Authors:  Chuanyun Li; Tong Zhou; Jing Chen; Rong Li; Huan Chen; Shumin Luo; Dexi Chen; Cao Cai; Weihua Li
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

Review 6.  Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins.

Authors:  Soudeh Ghafouri-Fard; Bashdar Mahmud Hussen; Mahdi Mohaqiq; Hamed Shoorei; Aria Baniahmad; Mohammad Taheri; Elena Jamali
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244

Review 7.  Potential utility of miRNAs for liquid biopsy in breast cancer.

Authors:  Xiangrong Liu; Dimitri Papukashvili; Zhixiang Wang; Yan Liu; Xiaoxia Chen; Jianrong Li; Zhiyuan Li; Linjie Hu; Zheng Li; Nino Rcheulishvili; Xiaoqing Lu; Jinfeng Ma
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.